Clinical Scorecard: Exploring the Clinical Features and Proteomic Profile of Relapsing Polychondritis with Respiratory Complications

At a Glance

Key Highlights

• Respiratory involvement is a major cause of mortality in RP patients.
• Patients with respiratory involvement often misdiagnosed due to symptom overlap with chronic respiratory diseases.
• Latent class analysis identified three subgroups based on bronchoscopic findings.
• Complement and NETs-related proteins may play a role in the pathogenesis of respiratory-involved RP.
• Recognition of imaging and bronchoscopic features can facilitate diagnosis.

Guideline-Based Recommendations

Diagnosis

• Diagnosis of RP with respiratory involvement should be based on clinical criteria and confirmed by imaging and bronchoscopy.

Management

• Management strategies should consider patient stratification based on airway involvement patterns.

Monitoring & Follow-up

• Regular follow-up every three to six months including symptom assessment and imaging studies.

Risks

• High risk of ICU admission and tracheostomy in patients with extensive airway involvement.

Patient & Prescribing Data

77 patients with relapsing polychondritis and respiratory involvement.

Non-invasive ventilation required for patients with significant airway damage.

Clinical Best Practices

• Utilize imaging and bronchoscopic features for accurate diagnosis.
• Implement regular monitoring of respiratory function and inflammatory markers.
• Consider proteomic profiling for understanding pathogenesis and potential biomarkers.

Related Resources & Content

• Clinical Features of Relapsing Polychondritis
• Pathogenesis of Autoimmune Diseases